Nelson Labs
Leachable compounds are currently only evaluated on the toxicological risk they pose to the patient. The effects that leachable compounds have on the quality and safety of pharmaceutical drug products, especially protein drug products, is often overlooked. Interactions of reactive leachable compounds with protein drug products can lead to a loss of efficiency, decrease of stability and increased immunogenicity in the patient population at risk. This webinar describes reactive leachable compounds, the scientific basis to predict leachable-protein interactions and a proof of concept.
Watch Now
To improve the commercial and ecological efficiency of your catalytic processes, you must develop better catalyst materials and optimize the reaction conditions. Now there’s a new analytical technology that makes this difficult job easier.
Watch Now
The chemical processing industries are among the top of all heavy industries in CO2 emissions.
Watch Now
Two years after the adoption of the EU Chemicals Strategy for Sustainability (CSS), the revamp of key EU chemicals and products regulations is underway.
Watch Now